Pfizer and BioNTech
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
August 30, 2023 10:00 ET | BioNTech SE
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical data...
Pfizer und BioNTech
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron XBB.1.5 angepassten COVID-19-Impfstoff in der Europäischen Union
August 30, 2023 10:00 ET | BioNTech SE
Der aktualisierte COVID-19-Impfstoff ist auf die Omikron XBB.1.5-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen Daten, die...
SPEClogoreg (1).jpg
SPEC Forms International Standards Group
September 27, 2022 04:00 ET | SPEC
GAINESVILLE, Va., Sept. 27, 2022 (GLOBE NEWSWIRE) -- The Standard Performance Evaluation Corp. (SPEC) announced the formation of the International Standards Group (ISG) to collaborate with...
logo.jpg
Helsinn announces European Commission approval of the liquid formulation of AKYNZEO® (fosnetupitant/palonosetron)
December 02, 2021 04:30 ET | Helsinn Healthcare S.A.
Helsinn announces European Commission approval of the liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) Lugano, Switzerland, December 2, 2021 – Helsinn Group, a fully integrated, global...
thumbnail_PHOTO-2021-11#5A2
Pomilio Blumm wins record €200m EU tender for communications
November 26, 2021 07:41 ET | Pomilio Blumm
ROME, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Pomilio Blumm has won a tender issued by the European Commission for €200 million over four years. The agency will be responsible for the design and...
Pfizer and BioNTech
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
November 25, 2021 07:30 ET | BioNTech SE
NEW YORK and MAINZ, Germany, November 25, 2021—Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use...
Pfizer und BioNTech
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für COMIRNATY® bei Kindern von 5 bis unter 12 Jahren in der Europäischen Union
November 25, 2021 07:30 ET | BioNTech SE
NEW YORK, USA und MAINZ, Deutschland, 25. November 2021—Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass der Ausschuss für Humanarzneimittel...
Logo 1.png
Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
July 29, 2021 08:05 ET | Aeterna Zentaris Inc
CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and...
Sweegen’s Bestevia® Rebaudioside M Approved in Europe
July 15, 2021 04:00 ET | Sweegen
Rancho Santa Margarita, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- Sweegen’s footprint in Europe became stronger after the European Union Commission published its approval of Sweegen’s non-GMO...
Pfizer and BioNTech
Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
May 20, 2021 05:00 ET | BioNTech SE
New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million dosesAdditional dose deliveries beginning December 2021 through...